Repligen: Q1 Earnings Snapshot
WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Repligen Corp. (RGEN) on Tuesday reported...
Stay updated with breaking news from Repligen Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Repligen Corp. (RGEN) on Tuesday reported...
Repligen (NASDAQ:RGEN – Get Rating) updated its FY23 earnings guidance on Tuesday. The company provided EPS guidance of $2.35-$2.42 for the period, compared to the consensus EPS estimate of $2.64. The company issued revenue guidance of $720-$760 million, compared to the consensus revenue estimate of $779.97 million. Wall Street Analyst Weigh In A number of […]
Geneva Capital Management LLC reduced its position in Repligen Co. (NASDAQ:RGEN – Get Rating) by 8.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 129,065 shares of the biotechnology company’s stock after selling 12,348 shares during the quarter. Geneva […]
Repligen Corp RGEN reported Q1 FY23 sales of $182.66 million, down 12% Y/Y as reported, beating the consensus of $181.43 million. • Adjusted EPS fell 30.4% to…
Repligen (NASDAQ:RGEN – Get Rating) is scheduled to be releasing its earnings data before the market opens on Tuesday, May 2nd. Analysts expect Repligen to post earnings of $0.59 per share for the quarter. Repligen has set its FY23 guidance at $2.61-2.69 EPS and its FY 2023 guidance at $2.61-$2.69 EPS.Persons that are interested in […]